Premium
Aligos Therapeutics Inc (ALGS)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
Aligos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapeutics to address unmet medical needs in liver and viral diseases. Its drug candidate, ALG-055009, a small molecule THR-ß agonist that is in the Phase 2a clinical trial for the treatment ... Aligos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapeutics to address unmet medical needs in liver and viral diseases. Its drug candidate, ALG-055009, a small molecule THR-ß agonist that is in the Phase 2a clinical trial for the treatment of metabolic dysfunction-associated steatohepatitis and obesity. The company also develops pevifoscorvir sodium, a capsid assembly modulator, which is in Phase 2 B clinical trial; and ALG-097558, a small molecule ritonavir-free pan-coronavirus protease inhibitor which has completed a Phase 1 clinical trial for the treatment of coronavirus. The company has entered into license and research collaboration agreement with Emory University; and Katholieke Universiteit Leuven. Aligos Therapeutics, Inc. was incorporated in 2018 and is headquartered in South San Francisco, California. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.14 | 2.49554367201 | 5.61 | 5.94 | 5.3 | 49399 | 5.55511709 | CS |
| 4 | 0.39 | 7.27611940299 | 5.36 | 5.94 | 4.8 | 79060 | 5.28583112 | CS |
| 12 | -2.39 | -29.3611793612 | 8.14 | 8.97 | 4.8 | 225957 | 6.81287503 | CS |
| 26 | -3.82 | -39.9164054336 | 9.57 | 10.49 | 4.8 | 134899 | 7.03759345 | CS |
| 52 | -1.54 | -21.1248285322 | 7.29 | 13.6892 | 4.8 | 106836 | 7.90611746 | CS |
| 156 | 4.83 | 525 | 0.92 | 46.8 | 0.3482 | 211927 | 8.07052749 | CS |
| 260 | -15.41 | -72.8260869565 | 21.16 | 46.8 | 0.3482 | 237172 | 6.60675527 | CS |
Transactions différées
Pour obtenir des transactions en temps réel, améliorez votre compte
Passer à la version en temps réel| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
